SCHEMBL6435

SCHEMBL6435

Cc1noc(-c2ccc(Br)cc2)c1CC(C)N(C)C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
NPC1 O15118 5/20 0.37
ALDH1A1 P00352 5/20 0.37
TP53 P04637 2/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
LMNA P02545 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALOX5 P09917 1/20 0.35
PTPN1 P18031 1/20 0.34
MAPT P10636 1/20 0.34
LPAR1 Q92633 2/20 0.33
LPAR3 Q9UBY5 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426 0.77 LMNA (0.42) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL22257228 0.73 ALDH1A1 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL1279 0.73 CYP1A2 (0.43) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL1683 0.72 CYP1A2 (0.43) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL6483 0.72 CYP1A2 (0.43) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL3829 0.72 P2RX7 (0.42) RAB9ASMN1; SMN2NPC1TP53CYP1A2
SCHEMBL6329 0.72 CYP1A2 (0.36) RAB9ASMN1; SMN2NPC1ALDH1A1CYP1A2
SCHEMBL1185 0.71 CYP1A2 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL18597812 0.71 CYP1A2 (0.44) RAB9ASMN1; SMN2NPC1ALDH1A1TP53
SCHEMBL24042873 0.71 ALDH1A1 (0.42) RAB9ASMN1; SMN2NPC1ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed